No abstract available
MeSH terms
-
Chemoradiotherapy
-
Hodgkin Disease / pathology
-
Hodgkin Disease / therapy*
-
Humans
-
Male
-
Nivolumab / metabolism
-
Nivolumab / therapeutic use*
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Programmed Cell Death 1 Receptor / metabolism
-
Radiotherapy Dosage*
-
Treatment Outcome
-
Young Adult
Substances
-
Programmed Cell Death 1 Receptor
-
Nivolumab